子類別 圖書 [1/1] 專利 [0/7] 期刊論文 [44/44] 鄰近社群 余佳益 [17/17] 余冠儀 [40/40] 冷治湘 [61/89] 劉士任 [121/149] 司徒惠康 [71/72] 吳綺容 [84/84] 周彥宏 [46/58] 宋旺洲 [33/34] 廖經倫 [32/32] 張仲明 [2/2] 張堯 [44/44] 曾凡真 [34/34] 曾才騰 [9/9] 李敏西 [60/64] 杜鴻運 [50/50] 楊采菱 [133/134] 潘建雄 [18/19] 羅秀容 [96/97] 胡勇誌 [23/23] 莊再成 [104/153] 蕭樑基 [158/161] 蘇益仁(2002-2015) [190/195] 許修誌(2005-2010) [1/1] 許素菁 [27/30] 謝鐸源(2006-2014) [20/27] 郭書辰 [139/141] 陳俊宏 [61/62] 陳信偉 [83/110] 陳宜君 [38/38] 陳逢叡 [40/40] 黃明熙 [51/64] 黃盈綺 [6/6] 齊嘉鈺 [46/46] McDonald LC(1998-2000) [12/12] 何曼德(1997-2002) [38/39] 其他 [177/177] 朱清良(2005-2007) [4/4] 梁蘭蘭(1998-2006) [6/6] 黃崑巖(1999-2004) [4/4] 社群統計 近3年內發表的文件:7(13.46%) 含全文筆數:45(86.54%) 文件下載次數統計 下載大於0次:45(100.00%) 下載大於100次:43(95.56%) 檔案下載總次數:22914(0.43%) 最後更新時間: 2024-12-01 03:18 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Enhanced production of recombinant ... The stability and immunogenicity of... Propagation and immunological chara... Separation and purification of high... The uncoating of EV71 in mature lat... Intranasal immunization with zika v... 作為對抗腸病毒感染之免疫原的病毒顆粒及其製造 作为对抗肠病毒感染之免疫原的病毒颗粒及其制造 エンテロウイルス感染に対する免疫原としてのウイルス粒子およびその生産(... Novel strategies for the developmen...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目26-50 / 52. (共3頁) << < 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2015-06-09	Immunogenic compositions and uses thereof	US9051361B2/2015-06-09
2015-04-21	免疫原性組合物及其用途	I481717/2015-04-21
2015-04	Recombinant adeno-vaccine expressing Enterovirus 71-like particles against hand, foot, and mouth disease	PLoS Neglected Tropical Diseases. 2015 Apr;9(4):Article number e0003692.
2015-03	Review of enterovirus 71 vaccines	Clinical Infectious Diseases. 2015 Mar;60(5):797-803.
2014-10	Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases	Vaccine. 2014 Oct;32(47):6177-6182.
2014-09-08	Long-term immunogenicity studies of formalin-inactivated Enterovirus 71 whole-virion vaccine in macaques	PLoS ONE. 2014 Sep 8;9(9):Article number e106756.
2014-08-27	Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice	BioMed Research International. 2014 Aug 27;2014:Article number 878139.
2014-07-30	Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns	Journal of Virology. 2014 Jul 30;88(20):11658-11670.
2014-06-11	Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems	Biomed Research International. 2014 Jun 11;2014:Article number 670506.
2013-12	Monoclonal antibodies for diagnosis of enterovirus 71	Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2013 Dec;32(6):386-394.
2013-11-21	Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers	PLoS ONE. 2013 Nov 21;8(11):Article number e79783.
2013-11	Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV	Human Vaccines and Immunotherapeutics. 2013 Nov ;9(11):2378-2385.
2013-10-02	Heat Shock protein 90: Role in enterovirus 71 entry and assembly and potential target for therapy	PLoS ONE. 2013 Oct 2;8(10):Article number e77133.
2013-08	Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection	Journal of Virology. 2013 Aug;7(16):9064-9076.
2013-07-30	Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice	PLoS ONE. 2013 Jul 30;8(7):Article number e69858.
2013-05	A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine	Vaccine. 2013 May;31(20):2471-2476.
2013-02-25	Human SCARB2 transgenic mice as an infectious animal model for Enterovirus 71	PLoS ONE. 2013 Feb 25;8(2):Article number e57591.
2012-12	Production of EV71 vaccine candidates	Human Vaccine Immunotherapy. 2012 Dec;8(12):1775-1783.
2012-11-30	Immunological and biochemical characterization of Coxsackie Virus A16 viral particles	PLoS ONE. 2012 Nov 30;7(11):Article number e49973.
2012-09	Immunological evaluation and comparison of different EV71 vaccine candidates	Clinical and Developmental Immunology. 2012 Sep;2012:Article ID 831282.
2012-04	Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates	PLoS ONE. 2012 Apr;7(4):Article number e34834.
2012-01	Selection and characterization of vaccine strain for Enterovirus 71 vaccine development	Vaccine. 2012 Jan;30(4):703-711.
2012-01	Human SCARB2-Mediated entry and endocytosis of EV71	PLoS ONE. 2012 Jan;7(1):Article number e30507.
2011-09	Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process	Journal of Virological Methods. 2011 Sep;176(1-2):60-68.
2011-06	Identification and characterization of a cross-neutralization epitope of Enterovirus 71	Vaccine. 2011 Jun;29(26):4362-4372.

顯示項目26-50 / 52. (共3頁) << < 1 2 3 > >> 每頁顯示[10|25|50]項目